Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NCT: NCT06480227 · RECRUITING
Brief Summary
This is a multicentered, double-blind, randomized controlled, surgical trial of 358 women with inadequate symptom relief of stress urinary incontinence (SUI) or stress predominant mixed urinary incontinence (MUI) after conservative care. The Primary Aim is to determine the comparative effectiveness (as defined by "much" or "very much" better on PGI-I) of transurethral bulking agent (TBA) \[for 1 or 2 injections in 12 months\] vs. single-incision sling (SIS) 12 months after treatment intervention in women with predominant stress urinary incontinence (SUI).
Frequently Asked Questions
What is Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence?
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence is a clinical trial registered under NCT06480227. Current status: RECRUITING.
What is the status of NCT06480227?
The current status of NCT06480227 (Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence) is: RECRUITING.
When did Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence start?
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence started on 2024-08-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.